Yo Iwami President & CEO (M.D, Ph.D), MedPeer, Inc.
Dr. Iwami graduated from the Shinshu University School of Medicine and joined the Department of Cardiovascular Medicine at Tokyo Women's Medical University in 1999.
Yo established Medical Oblige Inc (now MedPeer,Inc.) in December 2004.
He launched MedPeer in August 2007.
MedPeer is a professional online social media for certified doctors to share insight of actual medical scene and now it holds more than 100,000 doctors (one of three doctors in Japan).
He continues to be active on the front lines of clinical site, still holding patient consultations once a week.
Takehiko Nomura Senior Director (Ph.D) of Frontier Business Office, Sumitomo Dainippon Pharma
Dr. Nomura graduated from the Graduated School of Pharmaceutical Sciences, Kyoto University and joined Sumitomo Dainippon Pharma (former Sumitomo Pharma). After the 10 years experiences of CMC research and planning/management, he worked for Global Corporate Planning and engaged in M&A of US subsidiaries and post-merger R&D integration in 2009-2012. After that, he still managed the global R&D portfolio and resource especially in CNS and Oncology area which are the primary focus of the company (2012-2019). As of April 2019, he has been assigned as a head of newly created division, "Frontier Business Office" and engaged in planning and business development for new innovative non-pharmaceutical healthcare such as digital therapeutics.
Koichi Ogawa Director & Senior Executive Manageing Officer, Mitsubishi UFJ Research & Consulting, Co., Ltd.
Mr. Koichi Ogawa joined Mitsubishi UFJ Research & Consulting (MURC) in 2018 as Director & Senior Managing Executive Officer. At MURC, he is leading Membership Business, Human Resource Development and SDGs related business/projects such as Global Health, which MURC newly embarked on to provide a solution for various social agenda from think-tank perspective. Previously, he had been a Global Head and General Manager of Transaction Banking Division in MUFG Bank.Prior to that, he also worked for Bank of Ayudhya (Krungsri Bank) in Thailand as Deputy Head of Commercial Banking, in which he contributed to improve the sophistication of corporate banking management.
Yuuri Ueda MedPeer,Inc./HIMSS & Health 2.0 Country Director, Japan
After acquiring B.A. in law at Waseda university, Yuuri became M.D. at Okayama university. Her subspecialities are plastic surgery and homecare medicine, mainly takes care of decubitus in elders at home. As well as continuing her clinical practice, she started her career as a director for Health 2.0 Asia - Japan from April, 2017. She is heavily motivated in integrating medical practice and technologies, as she sees real needs for technologies in clinical situation.
Junki Yoshioka CEO,Medical Design Engineer, NODE MEDICAL, Inc.
Based on the experience of nurses, I'm working on applying design and engineering to nursing.I started delivering “Digital Hospital Art(2014-)” to draw patients’ dreams to life by bringing the magic of digital art into hospitals. I have created interactive digital art for hospitals in collaboration with medical staff. Current work includes research on “Fab Nurse(2015-)”, looking into applications of digital fabrication technologies in nursing.
I'm interested in technologies that can be tailored to support patients and families by responding to their individual conditions and environment, and communities where collaboration occurs across fields, such as medical, art, design, engineering etc.
NODE MEDICAL, Inc.(2019-) was established to implement these research and practices into society.
Atsuko Murashima Vice director and Director, Center of Maternal-Fetal, Neonatal and Reproductive Medicine and Japan Drug Information Institute in Pregnancy,National Center for Child Health and Development
Dr. Murashima graduated from the University of Tsukuba in 1982, and worked as a trainee physician at Toranomon Hospital. She joined the Department of Rheumatology in Juntendo University in 1985.
Since 2002, she has worked as the head of maternal physicians at the National Center for Child Health and Development, and now, as the vice director of Center of Maternal-Fetal, Neonatal and Reproductive Medicine and the director of the Japan Drug Information Institute in Pregnancy.
She is a committee member of the Ministry of Health, Labour and Welfare and the Pharmaceutical and Medical Device System. She is the president of the Japan Society of Obstetric Medicine and a director of the Japan College of Rheumatology. She is conducting the AMED research group "The risks and benefits related to drug administration to pregnant and lactating women" as the principal investigator.
And, she is known as a writer on Obstetric Medicine.
Ryou Koshino Cartoonnist
Manga artist Ryo Koshino left his job at an advertising company at 30 to draw fulltime. His work focuses mainly on medical storylines, with two series, Ns’ Aoi and Town Doctor Jumbo!! being made into TV dramas. He wants his manga to reduce the communication gap between medical staff and patients. He is now working on two series, Haruo Takenaka, a story about a man in charge of public relations at a bank, and Hanauta, a story about nurses.
Ayumi Maruyama President, Triple Regards LLC
Ayumi Maruyama is a social entrepreneur, CEO of Triple Regards -digital and printing design agency to make healthcare service sparkle by art and design. Ayumi has been awarded a number of prizes and honors, including Tokyo Startup Gateway 2018 sponsored by the Tokyo Metropolitan Government and Japan Healthcare Business Idea Competition 2019 by Ministry of Economy, Trade & Industry. She earned her medical laboratory science degree from Kitasato University and experience of doing sales for Roche Japan -received achivement award for salesperson of the year in 2012. She also graduated from Musashino Art University with bachelor’s degree in science of design in 2018 and this combination of different disciplines, in particular, healthcare and design, is in itself quite unique. Her own experience of being diagnosed Type II Diabetes when she was 20 years old and has continued controlling it makes her business very forward-looking and practical at the same time.
Shinsuke Muto President, Tetsuyu Institute Medical Corporation Chairman, Integrity Healthcare Co., Ltd.
Dr. Shinsuke Muto M.D., Ph.D., EMBA, MPH
President, Tetsuyu Institute Medical Corporation
Chairman, Integrity Healthcare Co., Ltd.
Co-Founder & Medical Director, Tetsuyu Healthcare Holdings, Pte. Ltd.
President, Community Healthcare Coordination Platform, Inc.
With two decades of experience in the field of medicine, Dr. Shinsuke Muto is a certified internal medicine specialist and cardiologist who passed the US medical licensing examination (California) and holds both US CPA (Delaware) , EMBA (INSEAD) , MPH (Johns Hopkins).
After graduating from the Faculty of Medicine at the University of Tokyo in 1996, he received his doctorate later in 2002. With experience in cardiovascular internal medicine and emergency medicine, he also served as a court physician to the Imperial Household Agency before joining McKinsey & Company. In 2010, he launched Tetsuyu Institute Medical Corporation in Japan.
In 2015, he established Tetsuyu Healthcare Holdings with his INSEAD colleague in Singapore, and became a chairman of Integrity Healthcare in 2016.
Georgia Mitsi MBA, PhD, Senior Director, Frontier Business Office Sunovion
Dr. Mitsi was named as a 2018 PharmaVOICE 100 inspirational leader, recognized as a digital expert and transformational leader who is moving the industry forward using a variety of digital strategies and tools. She was also recognized by CenterWatch as a Top 20 innovator. Dr. Mitsi is a hands-on digital innovator with expertise in developing scientifically validated software, in health outcomes and health economics research and experience in pharmaceutical and health care industry consulting. Prior to joining Sunovion, Dr. Mitsi was Founder and Chief Executive Officer of Apptomics, which provided scientifically-validated mobile applications. Previously, she served in health economics and clinical research roles at United BioSource Corporation at Humana’s Innovation Center and held positions in Sales and Marketing in Pharmaceutical companies.
Yuta Hagiwara CEO, PREVENT Inc.
After graduation Nagoya University Graduate School of Medicine, Yuta Hagiwara engaged in cardiac rehabilitation as a physical therapist in Kitano hospital. After that, He founded PREVENT Inc. in 2016. PREVENT provides disease management programs for patients with chronic disease through a mobile app. They have been giving the program to about 100 companies and employees with diabetes, hypertension, stroke and myocardial infarction.
Kunihiro Nishimura, Ph.D. CEO, Founder, Xcoo, Inc.
Dr. Nishimura received the B.S., M.S., and Ph.D. degrees in engineering from the University of Tokyo in 2001, in 2003, in 2006 respectively. He was the assistant professor at Graduate School of Information Science and Technology, the University of Tokyo until 2011. He founded Xcoo, Inc. in 2011 and CEO of the startup that is focused on data analysis for cancer precision medicine located in Japan. They analyze next-generation sequence (NGS) data in clinical sequencing, especially for cancer patients. They have developed a total solution software for precision medicine, "Chrovis" ( https://chrov.is ). He was recognized by Ministry of Education, Culture, Sports, Science and Technology (MEXT) as “NISTEP researcher” based on the contribution of science and technology in 2018. Xcoo has been chosen winner of the MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan) Minister‘s Award under the Award for Academic Startups 2019 Program.
Hirohiko Iwasaki Managing Executive Officer, Nippon Life Insurance Company
Education：B.A. in Law, Waseda University, 1987
1987 Joined Nippon Life Insurance Company
2008 General Manager, Tokai Regional Headquarters
2010 General Manager, Group Life & Pension Department
2013 General Manager, Product Planning Department
2015 Executive Officer, Product Planning Department
2017 Executive Officer, Metropolitan Area Headquarters
2018 Executive Officer, Marketing Planning Department & CRM Planning Department
2019 Director Managing Executive Officer
(CRM Planning Dept., Product Planning Dept., Marketing Planning Dept. and Sales Representatives Human Resource Dept.)
Mitsuru Sugawara, Dr. Eng. President & CEO, QD Laser, Inc.
Dr. Sugawara graduated from a master's degree in physical engineering from the University of Tokyo in 1984 and joined Fujitsu Laboratories.
In 1995, he became a senior researcher at the optical semiconductor research department at Fujitsu Laboratories and a doctorate in engineering from the University of Tokyo.
In 2004, he became a specially appointed professor at the Institute of Industrial Science, University of Tokyo. After serving as the deputy director of the Nanotechnology Research Center at Fujitsu Laboratories in 2005, he launched QD Laser in 2006 and continues to serve as President.
June 2007: Prime Minister Award in Japan
July 2014: IEEE 2014 Aron Kressel Award
October 2016: Received the 16th Yamazaki-Teiichi Prize for Materials Science and Technology Promotion Foundation
Koji Ozaki CEO, MEDICTION,inc
After graduating from high school, I studied in China in 2007 and entered Peking University School of Medicine. I obtained a Chinese medical doctor's license after graduation and returned to Japan, where I received a Japanese doctor's license as well. I now works as a full-time doctor at the department of general medicine in a university hospital in Tokyo. The department specializes in medical inbound and treatment for foreign patients, and scripts more than 600 people per month.
Yoshitake Yokokura President, Japan Medical Association / Former President, World Medical Association / Former President, CMAAO
Dr. Yoshitake Yokokura graduated from the Kurume University School of Medicine in March, 1969, and worked for the surgery department of the University. After that he worked for the surgery department of the Detmold Hospital in West Germany for two years (1977-79) He has been President of the Yokokura Hospital since 1990.
He took office as President of the Fukuoka Prefecture Medical Association in 2006. He was elected as President of the Japan Medical Association in April 2012. He also served Council Member of the World Medical Association (WMA) from 2010 to 2016. He serves as President of the WMA (2017-18) and President of the Confederation of Medical Associations in Asia and Oceania (2017-18).
Minoru Moriya began his business career in MISUMI Group Inc., then co-founded M-OUT Inc., a company specializing in new business development, with the founder of MISUMI Group Inc., Hiroshi Taguchi. After successfully launching and selling multiple businesses, he established his own company, Moriya Minoru Office in 2010. He then began his career as a specialist in new business development and joined RAKSUL Inc. and Carepro, Inc. as Vice President. In 2018, Boutiques, Inc. and RAKSUL Inc, were listed on the stock market two months in a row. He currently serve as an advisor for several companies including, Hakuhodo Inc. and JAXA while holding post as a member of the expert committee for the Cabinet Office and senior advisor in AI at Shandong province China. One of his recent work include “Let's take a new step forward!”: DIAMOND, Inc..
Masahiko Yasuda Head of People, LUSH JAPAN CO,LTD.
After graduation of Nanzan University in 1989, Masa started his HR career at SEIYU LTD as the staff of recruiting and training. In 2001, he joined Gucci Group Japan and experienced Human Resources planning and development in general HR area. After then he moved to Johnson and Johnson and experienced organizational development, leading of talent management and M&A as HR Business Partner for 6 years. And then worked at AstraZeneca, he joined LUSH as Head of People in 2015.
Naoki Goto Manager, President Office, MedPeer, Inc.
Started his career at an independent strategy consulting firm in 2013, Naoki Goto has engaged in developing a number of new business and medium term business plans in IT& Life Science field. After joining MedPeer, Inc. in 2017, he took part in establishing business partnerships as well as launching “CASEPEDIA", a case reports sharing service on the MedPeer platform.
Also in June 2019, he launched a pharmacy solution service “kakari”. Its goal is to support community pharmacies in the today’s changing market, by helping them to become patients’ primary pharmacies.
Taro Yokoyama Hospital director, Yokoyamaiin home ・palliative care clinic Koutokukai Medical corporation association
I’m a doctor, working in oncological examinations such as chemotherapy, palliative care units, and home care services.
A disease suffering has been shifting from completely recoverable diseases like an infection to chronic ones such as cancer and dementia.
From now on, I think it’s more important in medical care to think about how we live with diseases and disabilities.
When you are diagnosed, information and carers are essential for your better decision-making.
So, I made explanatory videos that patients could watch at anytime. Re-designing social education makes us possible to discuss about diseases in our community, with family and friends.
Yuki Shimahara CEO, LPIXEL Inc.
Dr. Shimahara completed his graduate studies and Ph.D. at the Graduate School of Frontier Sciences at the University of Tokyo. Yuki started his career at GREE Inc., where he took part in business strategy and human resources management. At the second IT firm, Yuki gained experience in global business development. He later established LPIXEL Inc. in March 2014 along with his two colleagues studying in the same university laboratory. Yuki was selected to join the Next Innovator 2015 Project in Silicon Valley, which was hosted by the Japan METI. He was also featured in Forbes Asia 30 under 30.
Shinya Minobe CEO, Yukashikado Inc.
Graduated from Kansei Gakuin University. In 2006, joined Recruit Co., Ltd., worked in the recruitment area, and worked on free paper. After that, he was transferred to Gochimaru Co., Ltd., a JV of Recruit and Oisix. Retired from Recruit Co., Ltd. in 2013. In the same year, he established Yukashikado Inc.
Graduated from the Department of Life Science and Technology, Tokyo Institute of Technology(TIT), 2008. Graduated from the Department of Architecture, TIT, 2011.
After graduating, Ryo joined a mobile IT company. He had worked as a director of planning and service glowth for womens' healthcare service and launching genetic testing service.
In Nov 2014, he Joined Recruit Lifestyle Co. and assigned to a business development division. He launched "Seem" -sperm selfcheck service- as a new business, and now is in charge of the strategy formulation of the entire Seem project, UX, and product development.
-Good Design Award 2016 Special Award : Future C12
-Japan Health Care Business Contest 2017 : Excellence Award
-Cannes Lions 2017 Mobile category : Grandprix, Gold, Silver
-Cannes Lions 2017 Glass category : Bronze
Kazumi Nishikawa Director, Healthcare Industries Division Commerce and Service Industry Policy Group, METI
July 2017－ Director Healthcare Industries Division Commerce and Service Industry Policy Group, METI
Oct 2018－World Economic Forum Global Future Council Human Enhancement and Longevity
2016 – 2017 Director for Trade Strategy, Trade Policy Bureau,
Director, Global Economic Policy Unit, Minister’s Secretariat
Ministry of Economy Trade and Industry (METI), Government of Japan
2013 – 2016 Executive Director, Japan External Trade Organization (JETRO) Singapore
Special Advisor to the Minister, METI
2012 - 2013 Director for Policy Planning (Growth Strategy)
Economic and Industrial Policy Bureau, METI
2009 - 2012 Principal Deputy Director
Policy Planning and Coordination Division, Minster’s Secretariat, METI
2008 - 2009 Principal Deputy Director
Small and Medium Size Enterprises Finance Division, METI
2006 - 2008 Deputy Director
Multilateral Trade System Department, METI
2004 – 2006 Deputy Director
Defense Policy Division, Japan Defense Agency (Ministry of Defense)
Education: BA, Faculty of Law, University of Tokyo, 1996
LLM, Northwestern University School of Law, 2003
LLM for International Study, Georgetown University Law Center, 2004
Attorney at Law, NY State, USA
Yuji Yamamoto is a founder and chief executive officer at MinaCare, Co., Ltd. which helps health and productivity management through health data analysis and community engagement promotion. He concurrently serves as an advisor of the Ministry of Health, Labour and Welfare, and as a member of committees of the Ministry of Economics, Trade and Industry, dedicating health care system reform. He is also active in education through his lecture series for healthcare, business, and government leaders.
Before starting these careers, Yuji spent six years as a practitioner in several leading hospitals including University of Tokyo Hospital and Tokyo Metropolitan hospitals.
Yuji received his M.D. degree from University of Tokyo and his medical license. He is a board certified member of the Japanese Society of Internal Medicine and holds an M.B.A. from Harvard Business School.
Ryo Okubo CEO, Rehab for JAPAN, Co., Ltd.
Occupational Therapist. Engaged in clinical rehabilitation work for seven years as a specialist through in-home care (day care services/ home-visit care services) and medical institution emergency care.
Founded Rehab for Japan Co., Ltd. in June 2016, serving as President.
Established the REHA PLAN, rehabilitation SaaS business for day-care service providers in February 2018, which expands Rehab for Japan services to provide rehabilitation for 25,000 individuals requiring long-term care.
MA in Policy Studies from Hosei University
Masashi Kiyomine Kicker Ventures, CEO
Masashi is the founder & CEO of Kicker Ventures and has been active early stage venture investor in the healthcare space since 2004. Previously, Masashi was Global Life Sciences team leader and Investment Director at Mitsui Global Investment where he began his career investing in medical device start ups, and later broadened his focus to include digital health and healthcare services. He served as board of director or observer for goBalto (acquired by Oracle), ChangeHealthcare(acquired by Emdeon), NxThera (acquired by Boston Scientific), CSI (Nasdaq:CSII). Masashi is an adviser of Innohub, a METI program, supporter of Link-J, and columnist for Nikkei Beyond Health.
Yoshinori Mizuguchi Director CSO Metabologenomics, Inc.
Dr. Yoshinori Mizuguchi co-founded Metabologenomics, Inc. and was appointed director of the company in 2015, when he was a master course student at the Tokyo Institute of Technology, Tokyo Tech. He completed a Ph.D. course of the Graduate School of Bioscience and Biotechnology at the Tokyo Tech and the Program for Leading Graduate Schools, Education Academy of Computational Life Sciences at the Tokyo Tech, supported by the MEXT and JSPS in 2018. Metabologenomics, Inc. is a leading company developing technologies for stratified medicine and healthcare in hopes of realizing a zero-disease by modulating intestinal environment, "Intestinal Design".
Harold (Hal) Wolf III President & CEO, HIMSS
Harold (Hal) Wolf III, is the President and CEO of the Healthcare Information and Management Systems Society (HIMSS). HIMSS consists of HIMSS North America, HIMSS International, cause-based, global membership societies; HIMSS Analytics, the market research and data services group; HIMSS Media, the diversified media and publishing division; PCHAlliance, the Personal Connected Health Alliance; and Health 2.0 the Digital Health Conference - all focused on better health through information and technology.
With nearly 35 years of experience, Wolf is respected internationally as a healthcare and informatics executive with areas of expertise in mhealth, product development, integrated care models, marketing, distribution, information technology and innovation implementation. He has helped health systems and providers across the world with end-to-end operations, commissioning, data and architectural design.
Bruce Steinberg Managing Director Executive Vice President, HIMSS International
Bruce Steinberg is the Managing Director and Executive Vice President of HIMSS International. HIMSS, a mission driven non-profit, is a global advisor and thought leader supporting the transformation of health through information and technology.
In his role, Bruce is focused on leading HIMSS’ international operations to address the global need and demand for improvements in the quality, safety, and efficiency of healthcare.
Bruce has more than 30 years of international experience in leading the growth and transformation of innovative businesses, from MTV Europe, UK Gold & Living TV, Fox Kids to Sky and People Tree.
Immediately prior to joining HIMSS, Bruce was CEO of Big White Wall, an online international platform for mental health services. Big White Wall provides a safe and anonymous 24/7 online community with digital resources for mental health and well-being support.
Bruce continues to be a Member of the Council for Beyond Type 1 (Diabetes) and a Trustee of the Unforgettable Foundation (Dementia).
Bruce earned an MBA from Harvard Business School, an MA (Cantab) from Cambridge University and a BA from Columbia University. He is based in London.
Dr. Charles Alessi Chief Clinical Officer, HIMSS
Dr Charles Alessi is HIMSS Chief Clinical Officer. He brings a wealth of experience and knowledge around health and care. He is also Senior Advisor to Public Health England, an executive agency of the UK government. He is also Adjunct Research Professor in Clinical Neurosciences at the Schulich school of Medicine at the University of Western Ontario, Canada and Visiting Scholar at the Odette School of Business, in Windsor Ontario, Canada. He is a primary care physician and was until recently , Chair of the National Association of Primary Care in England.
Ryosei Wakabayashi President & CEO, neumo,Inc
After leaving Andersen Consulting (currently Accenture), Ryosei Wakabayashi founded beBit in 2000. He assumed the office Vice President in charge of strategy and organization planning, human affairs, and recruitment. In 2016, he established a venture capital subsidiary in the United States with a focus on ventures working on EEG devices and AI technology for epileptic patients in the U.S., Israel and Japan. The R&D Division began joint research with Kyoto University and Stanford University. In 2017, after establishing neumo, Inc., which specialized in neuroscience, he led a wide variety of joint research projects with UCLA and private-sector companies. Neumo, Inc currently focuses on music-neuroscience collaboration with the aim of developing products that improve acoustic sensitivity.
Seigo Hara CEO, MICN
Seigo is the founder and CEO of MICIN, a healthcare startup focusing on advancing health decisions through data. He has been committed to improving the healthcare system throughout his career, namely through his work at International Medical Center of Japan, Health and Global Policy Institute, and McKinsey prior to founding MICIN. He currently teaches Clinical Statistics at Yokohama City University School of Medicine.
Yuya Kikukawa CEO / Founder, no new folk studio Inc.
After graduating from Hitotsubashi University School of Commerce, majored in art engineering at Tokyo Metropolitan University. Established no new folk studio Inc. in the wake of commercialization of smart footwear “Orphe”, which was developed as a research on new musical performance interfaces in 2014. He has received numerous awards including the Japan Media Arts Festival, Plug and Play Japan IoT Batch 2 EXPO Winner, and the ASICS Accelerator Program Grand Prize.
Tomohiro Myojo Director of the Precision Medicine Center, Edogawa Hospital
It was born in Okayama for 1976
I am a graduate from the Kumamoto University medical department for 2001
After Okayama University hospital, I loaded the clinical study that it was of the cancer treatment in Kure Kyousai hospital, Toranomon hospital , The Cancer Institute hospital and was engaged in a setup of the Department of Oncology and Hematology of the Edogawa hospital from 2009.
The cancer medical therapy specialist youngest pass that has difficulty with an acquisition cancer most.
It becomes the hospital which provides eminent cancer medical care in Tokyo now.
In addition, I play an active part as Hyper medical Creator becoming a listed company and the go-between of the hospital.
Diplomate, Subspecialty Board of Medical Oncology, JSMO, Board Certified Member of the Japanese Society of Hematology For a recent work "a teacher!" Please tell me the knowledge of a really right cancer (Subarusya)
Yoshiyuki Numata Representative director, Editor-in-Chief Monthly MIX, MIX, Inc.
After graduating Kitasato university in 1987, Yoshiyuki Numata joined in a foreign-capital pharmaceutical company, as a Medical Representative. With the advantage of his career,from 1992, he worked as a writer for dairy paper specialized for pharmaceutical region, interviewing the ministry of health, labor and welfare, doctors, pharmaceuticals. From Dec. 2008, he joined in Elsevier Japan Inc. as Chief editor for Monthly Mix, which succeeded to Mix Inc. on July 2017 and now he is CEO of Mix Inc.
Kazuma Kaneko CEO, Linc'well
Kazuma Kaneko, M.D., Ph.D.
Kazuma worked as a physician for 8 years mainly in Tokyo Univ. Hospital. During that period, Kazuma researched in molecular biology and got Ph.D., from Tokyo Univ.
In 2011, Kazuma joined McKinsey and Company then supported global projects (e.g., U.S., Europe, and Asian countries) in healthcare industry.
In 2018, Kazuma founded Linc’well Inc. aspiring to transform healthcare practice through technology.
John H. Daniels CNM, FACHE, FHIMSS, CPHIMS Global Vice President, Healthcare Advisory Services Group HIMSS Analytics
John H. Daniels is Global Vice President for HIMSS Analytics at HIMSS, a global advisor and thought leader supporting the transformation of health through the application of information and technology.
For over 30 years, Mr. Daniels’ career has spanned behavioral healthcare, healthcare IT, hospital administration, and military healthcare. He currently leads HIMSS Analytics’ global healthcare advisory services team supporting healthcare provider organizations and government health authorities around the world.
As an expert in health IT issues and trends, Daniels frequently speaks at conferences around the world. He serves on the ACHE Board of Governors Examination Review Course faculty, has lectured at Boston University, and was a graduate Adjunct Professor for Pfeiffer University.
Daniels holds a BS degree in Computer Science, a MS degree in Health Services Administration, and a graduate certificate in Nonprofit Management. He is a Certified Healthcare Executive, holds the CPHIMS credential, and is a HIMSS and ACHE Fellow.
Kakuya Niihata Director, Moderation in Health Care Costs Promotion Office, Division for Health Care and Long-term Care Integration, Health Insurance Bureau, Ministry of Health, Labour and Welfare, Japan
Dr. Niihata graduated from Osaka university school of medicine in 2007.
After working as a physician, he joined Ministry of Health, Labour and Welfare in 2017. At the present post, he is engaged in specific medical checkup/specific health-maintenance guidance.
Tomohiro Masuhara Deputy Director, Information Applications Promotion Office, Advanced Information Systems and Software Division, the Ministry of Internal Affairs and Communications
Tomohiro Masuhara is Deputy Director,Information Applications Promotion Office, Advanced Information Systems and Software Division, the Ministry of Internal Affairs and Communications (MIC), Government of Japan. He has been in his current position since June 2018 and is in charge of promoting ICT in the medical field. He also has broad experience as the First Secretary, Embassy of Japan in Malaysia, Deputy Director, Broadcasting Policy Division, and so on.
Shinichiro Ito CEO, AGREE Inc.
Former cardiac surgeon at Tsukuba University Hospital. Ito Established a medical corporation in 2015 and has expanded the business to annual sales of 1.5 billion yen in the fourth year. Continuously, Ito Established AGREE Inc., which develops telemedicine consultation services in 2017. Achieve a track record of reducing health concerns in doctor-deficient areas. Won the Ibaraki Prefecture Achievement Award in 2018.
Shiho Azuma CEO, Lily MedTech, Inc.
Shiho Azuma was born in Japan, in 1982.
She studied physics and aerospace engineering in university.
In 2009, she entered a graduate university as a Ph.D student in JAXA. However, right after admission, she lost her father by unexpected death. Because of economic reason caused by it, she dropped out of the university. She worked for a measuring equipment manufacturer. She was engaged in development of the next generation of NMR in both development and production divisions
After that, her husband, a researcher of medical ultrasound diagnosis and treatment system in the University of Tokyo, invited her to launch a business together. Shiho started up a business in 2006, to save young ladies, mothers and their families with her personal motivation that she lost her mother to brain cancer when she was a high school student. Lily MedTech, Inc., has fund-raised about 14 million usd so far.
Misa Nishimoto CEO, LaundryBox.inc
After working at a PR company, Misa Nishimoto joined DWANGO Co., Ltd., where she continued working in PR. She became independent in 2016. Writing a blog while working as a company employee increased her interest in women's body and gender, which motivated her to establish Laundry Girl, a web media site. In February 2019, she founded LaundryBox.inc. In August 2019, she opened the LaundryBox, a media commerce site featuring articles and products of interest to women. These include issues such as menstruation. It handles sanitary goods, care goods, and FemTech products. http://laundrybox.jp
Takeshi Ogawa Senior Researcher, Advanced Telecommunications Research Institute International
Dr. Takeshi Ogawa obtained a Ph.D in 2011 at Tohoku University. His interest was to understand a neuronal population dynamics with laminar profile in the primary auditory cortex of rodents. Since 2012, he has been working in Advanced Telecommunications Research Institute International (ATR), where he developed the brain machine interface in the real-world environment using portable electroencephalography (EEG) and near-infrared spectroscopy (NIRS) as a researcher. Dr. Ogawa's main scientific interests are i) network dynamics at rest or task, ii) understanding of mechanism associated with creative insight.
Yoshinori Abe CEO Doctor, Ubie Inc.
Co-Founder and CEO of Ubie Inc., a company committed to improving healthcare outcomes with the power of machine learning. Founded Ubie Inc. after experiencing first hand, the difficulty of timely and accurate diagnosis, and the pain of losing patients to diseases that could have been saved if treated earlier. With self-taught data-science and the help of Co-Founder CEO Kota Kubo, developed an “AI medical interview system” based on data from over 50,000 clinical research papers. Founded Ubie Inc. in 2017 to provide “AI-Monshin” (AI medical interview system) to hospitals nationwide. Received a Medical Degree (M.D.) from Tokyo University, School of Medicine in 2015, and completed residency at Tokyo Metropolitan Geriatric Hospital and Longevity Medical Center.
Ai Sonoda President, Integrity Healthcare Co., Ltd.
Ai Sonoda MBA , MMA
President, Integrity Healthcare Co., Ltd.
Ai Sonoda worked at a medical consulting company and joined the business development department of Recruit Co., Ltd.
In 2009, she founded Integrity Healthcare Co., Ltd., and co-founded Tetsuyu Institute Medical Corporation in 2010.
Since 2011, she moved to the area which was most seriously damaged by the East Japan Earthquake, opened home medical care clinic and established a community comprehensive care system.
In 2015, she launched the Digital Therapeutics business at Integrity Healthcare Co., Ltd.
Co-Founder & Special Advisor to Tetsuyu Institute Medical Corporation.
Vice Chairman of Institute for Healthcare Leadership.
Completed the Graduate School of Tokyo Medical and Dental University.
Kenji Kajiwara CEO, Chikaku.Inc
After graduating from college, he joined Apple Japan, Inc. He headed major sales and marketing departments handling consumer products such as iPod for 12 years. He became independent in 2014 and founded Chikaku Inc. in the same year.
Masashige Den CEO, Dr.'s Prime Inc.
After training at St. Luke’s International Hospital, he began practicing emergency medicine. His experience having to reroute emergency patients due to insufficient beds at peak times prompted him to establish Dr.’s Prime Inc. in 2017.
He also received the Best Presenter Award at Start Next Innovator 2018 (Global Entrepreneur Program) organized by the Ministry of Economy, Trade and Industry.
Jun Fukuyoshi CEO, Cancerscan
Jun harnessed his marketing skills at Procter & Gamble for seven years. After the graduation from HBS in 2008, he founded Cancerscan, which was the first social marketing agency in Japan. Targeting cancer mortality decrease as Cancrscan’s first priority, Cancerscan developed a behavior change strategies and executions for cancer screening uptake program.
After graduating from the University of Tokyo's Faculty of Law, he joined Boston Consulting Group. In 2006 he launched Japan's first flat-rate unlimited music listening service with Napstar.Subsequently, he started a number of services centered on the entertainment and communications field in RecoChoku Co., Ltd. and DeNA Co., Ltd. In 2015, he rejoined BCG and established the BCG Digital Ventures Tokyo Center.In January 2019, he was appointed First Vice President in charge of New Business at Aflac Life Insurance Ltd and as Representative & Managing Director, Aflac Innovation Partners G.K. in February 2019.
Shinichiro Nakaishi President, universal sound design inc.
I’m a researcher at Hiroshima University’s Space Regeneration Medical Center.
・In 2013, I founded USD because I wanted to use my knowledge of speaker technology to help people with hearing problems.
・The main reason is because 2 members of my family – my grandmother and my father – had hearing problems
・Fortunately their problems were not severe, but they often interfered with communication
Yasuko Akutsu President & CEO of MT Healthcare Design Research Inc
Ambassador of Aging2.0Tokyo
Representative Director of Advanced Gerontology in Next Generation Japan association
Graduated the masters program at the University of Tukuba graduate school of Environment science. I joined GK industrial Design Institute, engaged in marketing research of product and urban development master plan.
I started MT Healthcare Design Research Inc.in 2012, MT Healthcare Design Research inc, is company specialized in a health care design, product design , system design, ux design, business design.
Katsunori Sugiura President of Sugi Pharmacy Co., Ltd.
Graduated from Pharmaceutical School of Gifu Pharmaceutical University in 2001.
Joined Johnson End Johnson Co., Ltd. in 2003
2006 Joined Sugi Pharmacy Co., Ltd.
In 2017 he took office as President and Representative Director of Sugi Pharmacy Co., Ltd.
We will deepen the area of "maintenance of health", "premature illness" and "prevention", so that everyone in the community can live a healthy and pleasant social life both physically and mentally, by experts on improving "eating habits" and "moderate exercise" Promoting realization of "wellness" of customers by supporting maintenance and promotion of aggressive health such as advice
"Based on the philosophy of" wishing for the happiness of all people and increasing the smile ", we aim at the existence which can be relied upon from the community at ease, conveniently and casually.
Shin Nakayama Dai-ichi Life Holdings, Inc. The Dai-ichi Life Insurance Company, Limited (General Manager of Marketing Strategy Dept. Director of Dai-ichi Life Innovation Lab)
Join The Dai-ichi Mutual Life Insurance Company (now The Dai-ichi Life Insurance Co., Ltd.) in 1997.Experienced in branch office, government office (trainee), Invest Planning Dept., Corporate planning dept., as well as IT Business Plannning Dept..
(in charge of IT strategy, IT governance, IT investment etc.).
Since April 2018, he leads the innovation as general manager of Marketing Strategy Dept. and Director of InsTech Development Center (Director of Dai-ichi Life Innovation Lab).
Shuri Marui Co-Founder and CRO of HERBIO., INC. Assistant Professor of Faculty of Human Sciences, Waseda University
Shuri Marui received PhD of Graduate School of Human Science in 2018.
She has been mainly researching about thermoregulation of perimenopausal women using rats.
Recent research project is prediction of basal body temperature in women.
Since December of 2016, Ms. Marui has joined HERBIO,. INC. as Co-Founder and CRO, and engaged in the development of the wearable thermometer.
Maaya Hine Executive Board Member,General Manager of Lunaluna Business Department Heathcare Business Organization, MTI Ltd.
Graduated from Yokohama City University School of Commerce in 2004.
Joined MTI in 2006, after working at trading company as a new graduate.
Engaged in advertising and marketing for “Lunaluna”, and asigned as Chief Manager of Lunaluna Business Department in 2012.
While expanding a business model from the BtoC subscription model to the freemium model and to the women's healthcare platform, she raised “Lunaluna” into a major brand that many Japanese women use, and improved customer value through activities with medical institutions and government.
Chikara Matsuzaki RIZAP Personal Trainer Japan Top Trainer Association certified JTTA health exercise instructor
Musashino city, TOKYO
•New York State University of NY College at Cortland Physical Education
•Start working at sports club in TOKYO
•Exercise coach at Neurosurgery hospital in HIROSHIMA
•Participation in RIZAP, in charge of global education and Medical service
•In charge of overseas store and monitoring in Japan
Kazuya Iinaga CEO, Medhical Photonics Co.Ltd.
Worked for 16 years at a pharmaceutical company and worked as a researcher at Hokkaido University. Founded Medical Photonics Co., Ltd. in February 2015. In the corporate era, I got the opportunity to learn about lipid testing, and that experience became the cornerstone of this project. The experience of sales and the experience from the customer's perspective is also the trigger of this project. In January 2020, the Smart Nigori Checker “Calide” will be launched. In addition to the Nikkei Shimbun and Asahi Shimbun and HBC （Hokkaido TV）.
Fumito Shimizu CEO, 3Sunny
After working at Gree, Inc. and Recruit Holdings, Fumito Shimizu founded 3 Sunny, Inc. in August 2016 and became CEO. Based on his experience as a patient, he wanted to solve issues regarding medical and long-term care. He developed the Carebook web service series that connects medical and long-term care facilities applying solutions for arranging hospital discharge and transfer.
Mohmoud Chikh-Ali Commercial Attaché, U.S. Embassy, Tokyo
Mohmoud Chikh-Ali is a Foreign Service Officer with the United States Department of Commerce. Mohmoud served in the U.S. Embassy in Cairo, Egypt from 2016 – 2018 and the Department of Commerce Miami field office from 2015 – 2016. Most recently, he was on the Secretary of Commerce’s special project with Enforcement and Compliance working on self-initiation for anti-dumping and countervailing duties cases for the U.S. semiconductors, energy, and farming industries.
Mohmoud worked with U.S. companies entering the Egyptian market during the country’s economic reform program and advocated for U.S. firms on Egyptian-government supported projects. He advised the U.S. ambassador to Egypt on the trade and commercial situation in the region, including the U.S. strategy during trade policy negotiations with Egypt.
Before joining the Department of Commerce, Mohmoud worked in the oil & gas industry for ten years, primarily within the manufacturing and engineering services. He was a project manager for a mid-size engineering firm during their expansion into the Middle East North Africa region. Under his leadership, the company opened its first office in Saudi Arabia and doubled its client portfolio within 18 months. With Halliburton, Mohmoud was the client relations manager for the container unit division and worked with offshore clients such as ExxonMobil, Shell, and Chevron.
Mohmoud speaks Arabic, Spanish, and Japanese. He received his bachelors from the University of Houston and masters from Georgetown University.
Matthew Holt Co-Chairman, Health2.0
Matthew Holt, Co-Chairman, spent the 1990s learning from the best to be a health care futurist at Institute for the Future, and a survey researcher at Harris Interactive. In the early 2000s he spent time at a PHR start-up, but since he’s been the Founder of (and now occasional author on) The Health Care Blog, and co-founder of the Health 2.0 Conference–roles for which he was mostly self-taught!
Atsushi Mizuno Department of Cardiology / QI center, St.Luke's international hospital
Atsushi Mizuno is a clinical cardiologist and a vice director of QI (quality indicator) center at St. Luke’s International hospital, and also an associate professor of critical care nursing at St. Luke’s International University. In addition to the clinical works as a cardiologist, he developed several programs to improve quality of care in the hospital by using several business strategies. He now engages in several clinical studies and enhances his career by learning behavioral economic strategy especially in healthcare area.
Roy Tal CEO & Founder, 2gether
Roy Tal. 35 years old, a social entrepreneur. He graduated from various Accelerators including Hive (National Insurance Funds and JDC) and masschallange International & KGAP+ Japan Keihanna research city Was selected by The Marker as a list of 35 leading Israeli entrepreneurs under the age of 35. Graduate of the Singularity University in Silicon Valley and the Rimon School of Music. Founded in 2014 together with Shirley Winner the Imagine Association, which today brings musical education to children and adults with special needs in more than 90 groups around the country. In 2017 he founded 2gether, a company that helps families, volunteers and therapists take care of their loved ones by using a digital-therapy app. Today, 2gether provides services to more than 115 institutions throughout the country and takes its first steps overseas.
Victor Chapela Co-Founder & CEO, Suggestic
Victor Chapela is Co-founder & CEO of Suggestic, a Silicon Valley-based company whose mission is to help individuals make optimal food choices towards weight loss, disease management and optimal health. Suggestic uses artificial intelligence and augmented reality to overlay and score what is best for you from a restaurant menu, at the grocery store or at home when cooking.Mr. Chapela has over 25 years of tech startup entrepreneurship experience. During this time, he has founded and led 5 technology companies in the United States and Mexico. His latest companies: Sm4rt Security Services and Sm4rt Predictive Systems were both acquired in 2014.Mr. Chapela is an active angel investor and mentor in the Silicon Valley area. In addition to entrepreneurship and management, his main expertise lies within the areas of artificial intelligence, information security and risk modeling. Has been advisor to regulators, intelligence agencies, secretaries and presidents. He is author of books, patents, government regulations, courseware and white papers. He is a frequent keynote speaker and has been featured many times in business and trade magazines, television and radio.
Michihiko is the director of Real-World & Analytics Solutions in IQVIA Japan group. He is focusing on developing solutions leveraging Real World Data in Japan.
He started his career at Pfizer research center as a drug discovery scientist. After moving to management consulting field, he supported various clients in healthcare to formulate and execute strategies, ranging Corporate, R&D, Marketing and Policy Making. In MSD K.K., he was responsible for marketing director in Hematology & Women's cancer area and Corporate Strategy / Healthcare Innovation director as well.
Michihiko holds BS and MS degrees in bio science from Tokyo Institute of Technology.
Go Fujita MTG Ventures, Inc. CEO.
Graduated from Faculty of Economics, Meiji University. Then, joined Japan Associated Finance Co., Ltd.(Currently named, JAFCO Co.,Ltd.) in 1997. Transferred to the Investment Department, Chubu Branch of JAFCO in 2005 and promoted to the President of Chubu Branch in 2015. Participated in the investment support of various investment companies from start-up stage to later stage, and also acted as a Borad member of each invested company. Invested in the area of Auto-driving, AI, Childcare IoT, etc., and inversted to the splited companies. Based on the rich experience of working with over 5,000 management people, currently challenging for the investment area of BEAUTY-TECH, WELLNESS-TECH, FOOD-TECH and SPORTS-TECH.
Reiji Oishi Business Strategist, Digital Transformation Division, Softbank Corp.
Mr. Oishi joined SoftBank as a business strategist in May, 2018. He has been built alliances through negotiations with overseas companies, and proposed collaboration with customers and new business planning. Prior to joining SoftBank, he was in charge of joint venture projects in Southeast Asia, and established subsidiaries in India, Russia and UAE of GMO GlobalSign K.K. He has more than 10 years of experience in overseas expansion, operation and start-up management.
Dr. Shirono Biography
Dr. Yoshinori Shirono, M.D. and Ph.D., is the founder of Dr.Ci:Labo, the no.1 medical cosmetics skincare brand in Japan. After graduating from the Keio University School of Medicine, Dr. Shirono went on to specialize in dermatological laser surgery at the Japan Medical Laser Laboratory. He established the Shirono Clinic in 1995, offering state-of-the-art laser treatments, a wide range of anti-aging treatments and dermatological surgery.
While seeking the most effective skincare products for his clinical patients, Dr. Shirono could find nothing to meet his high standards and thus created his own masterful skincare line. Dr.Ci:Labo is the result of expertise, extensive research and continuous innovation. Dr. Shirono still works directly with patients today, which enables him to understand current needs and continually reflect the solutions to such needs in Dr.Ci:Labo products.
Dr Hee Hwang Clinical Information Officer, Seoul National University Bundang Hospital
As an associate professor and the CIO of Seoul National University Bundang Hospital (SNUBH), Dr. Hee Hwang has contributed to both innovations in medical management and developing new business opportunities by converging medicine with ICT. SNUBH is recognized globally as a leading digital hospital since achieving the HIMSS EMRAM Stage7 in 2010 and 2016. As the CIO, he facilitated the development of SNUBH’s next-generation hospital information system (HIS) in 2013. Beyond improving our hospital’s IT environment, he contributed to implementing a standard-based nationwide health information exchange system in South Korea. He conducted to adopt In-Memory based analytics platform into the CDW, enabling real-time analytics of over 500 clinical indicators. He published articles in journals proving the benefit of utilizing Big Data to improve quality of care and patient safety. Throughout his career, he was dedicated to connect the viewpoints between medical staff and IT professionals, providing intuitive awareness to them.
Low Cheng Ooi Chief Medical Informatics Officer, Ministry of Health, Singapore
A/Prof Low currently is the Chief Medical Informatics Officer (CMIO) of Ministry of Health (MOH), Singapore. As the CMIO of MOH, his work involves policy development and overseeing the operations of the National Electronic Health Record (NEHR) system in Singapore and other national Health IT programmes.
As Chair of the CMIO Council, he works closely with the other CMIO colleagues in the public healthcare sector to facilitate and implement the cluster electronic medical records systems.
A/Prof Low is currently Singapore's representative at the General Assembly of the International Health Terminology Standards Development Organisation (IHTSDO)/SNOMED International. He is an Honorary member of The Association for Medical and Bio-Informatics, Singapore (AMBIS) and a member of the American Medical Informatics Association (AMIA). He has been appointed as a member of the Healthcare Information and Management Systems Society (HIMSS) Asia Pacific Governing Council from 2014 to 2017. From 2008 to 2012, he served as Chief Medical Informatics Officer of Singapore Health Services Pte Ltd (SingHealth) where he was responsible for rolling out the Electronic Medical Record (EMR) while concurrently holding appointment as Chairman, Medical Board, Changi General Hospital.
A/Prof Low is an orthopaedic surgeon by training. He graduated from the National University of Singapore (NUS) in 1980 and obtained his FRCS (Glas) in 1985 & Fellow of the Academy of Medicine, Singapore (Ortho) in 1989. He was awarded Health Manpower Development Programme in 1998 for Advanced Orthopaedics and Hand Surgery. A/Prof Low is the recipient of the Public Administration Medal (Silver) in the 2016 Singapore National Day Award.
Masashi Omuro Occupational Physician, Doyukai Medical Corporation
Occupational Physician of Doyukai medical corporation since 2014. After graduating from University of Environmental Health, He completed clinical training at Omori Red Cross Hospital in 2007. Between 2007 and 2009, he studied the practice of occupational physicians and was conducting research on preventive medicine at Occupational Health Training Center.
He was an occupational physician of Johnson & Johnson k.k. from 2009 to 2014.
Currently, he is an medical adviser to 30 companies as an Occupational physician.
Mika Nakayama Medical Affaris Division, Janssen Pharmaceutical K.K.
Mika Nakayama joined Johnson and Johnson in 2012. She was in charge of the project to raise disease awareness of an orphan disease related to neurosurgery and advised to hospital managers and strengthed regarding medical cooperation. Currently, she has been leading the medical strategy of medical education for physicians or patients, and clinical studies. A project of digital content in her division is being focused on to promote shared decision making between patients and physicians through websites for patients or apps.
Snehal Patel MyDoc Pte. Ltd./CEO and co-founder
Dr. Patel moved to Singapore from the US in 2008 to found and lead the healthcare team at the Chandler Corporation, a multi-billion dollar investment fund. Prior to practising law at Cravath, Swaine & Moore, LLP in New York, Dr Patel received an MD and a JD from Columbia University and served as a Clinical Fellow at the Harvard Medical School.
Tomohiro Kuroda Professor / CIO Kyoto University hospital
Worked as a medical representative at Takeda Pharmaceutical Company Limited. Seeing patients waiting for a long time at hospitals and pharmacies, realized better user experience can be provided through better IT medical infrastrucutres. Founded KAKEHASHI, Inc. in 2016.
KAKEHASHI provides SaaS for pharmacies, which innovates patient experience at pharmacies and reduces paper work of pharmacists.
Toshio Miyata CEO, Medical Compass Corporation / Professor, Osaka University
President, MIH Clinic CEO, Medical Compass Corporation Professor, Osaka University
Dr. Toshio Miyata is a graduate of the Waseda University Department of Mechanical Engineering. He researched and developed artificial heart in the undergraduate. He dreamed to do clinical trial of artificial heart and decided to transfer to the Osaka University School of Medicine. He worked as a cardiac surgeon at the Osaka University Hospital and got involved in the medical treatment of the artificial heart and regenerative medicine but also encountered the problem of device lag which made him to enter the Ministry of Health, Labour and Welfare. He is widely engaged in healthcare reform in Japan; amendment of the Pharmaceutical Affairs Law; Regenerative Medicine Law; increase of clinical research budget; and regulatory reform of clinical trial. He currently works for "MIH clinic" which serves primary healthcare for the local and also offers dialogue with the residents of the community. He also started self-medication tool based on the smartphone technology to utilize the profession of medical doctor and pharmacists.
April 2016- present: Sugi Pharmacy Co., Ltd. Aichi
After working as a registered dietitian at a store for 3 years, she was assigned to the Self Care Promotion Office in 2019. Planning and operating self-care support service “Sugisapo” utilizing her experience as a registered dietitian.
Naoto Fukutani CEO, BackTech Inc.
BackTech is developing and operating “Pocket Therapist”, a countermeasure application for stiff shoulders and low back pain, based on medical evidence. We has received numerous awards, including receiving the Grand Prize at Health Tech's largest global conference, Health 2.0 Asia 2018.
Kuniyoshi Mabuchi PwC Japan LLC Experience Center/ Managing Director
After working at Sapient inc (US), established DOE Inc. in 1998 and appointed as the position of president. In 2005 established Profero Co., Ltd., a joint venture between UK digital media agency Profero inc and DOE. Appointed as President and Representative Director.
20 years of top management in the digital marketing industry, he became General Manager of Tribal DDB Tokyo in 2009, the Omnicom Group and succeeded in regenerating the group.
Since 2016, Omnicom Group, FleischmannHillard SVP & Partner. Since 2017, he has been an executive advisor at PwC Consulting for multiple companies.
In 2018, he was appointed as Facebook Japan Director, and achieved Instagram's 35 million MAU in Japan, second place in the world, and No. 1 Japan Revenue Growth in APAC.
Active in his current position from October 2019.
A member of the Japanese Society for Artificial Intelligence and a member of the Blockchain Council.
Akihiko Soyama President and Chief Executive Officer of LINK-J, Life Science Innovation Network Japan, Inc.
In 1986, Akihiko Soyama entered Ministry of Economy, Trade and Industry(METI). He engaged in trade negotiation such as WTO. He received his MBA from graduate school of business, Columbia University.After leaving METI, he joined The Boston Consulting group. Then, he moved to Trans-Cosmos Inc, as Senior Managing Director for Overseas Business and Corporate Strategy. Working in medical device industry, such as Johnson & Johnson KK as Vice President for DePuy Joint Division and Strategic Planning Division, Biotronik Japan Inc. as President/Representative Director and Haemonetics Japan GK as President, he was appointed President and CEO, Life Science Innovation Network Japan, Inc. in 2016. He is also a member of The Council for Fostering Medical Start-Ups of the Ministry of Health, Labour and Welfare, teaches at University of Tokyo and so on.
Manish Kohli Managing Director of Beyond Horizon Health Co-Founder and Partner, Infinite Care Holdings
A charismatic and visionary physician leader with demonstrated history of instrumental roles in pioneering health care endeavors globally, Dr. Kohli is passionate about transforming health and care through digital innovation. He is a champion for better access to quality care for every citizen, anywhere, anytime and is a highly skilled public speaker with expertise in complex healthcare “firsts”; digital health; informatics; clinical transformation; personal well-being and preventive health.
Dr. Kohli has extensive work experience in variety of international health care settings focusing on advancing health and care through the use of health information technology. He is a frequent invited speaker globally and has lectured extensively throughout Asia, Middle East and North Africa, US, Europe and Australia.
He serves as Managing Director of Beyond Horizon Health, a global digital health advisory and consulting firm. He is also a Co-founder and Partner, Infinite Care Holdings FZ-LLC.
Dr. Kohli is the immediate past Chairman, Board of Directors of Health Information and Management Systems Society (HIMSS), a global, 100,0000-member, cause-based, not-for-profit organization focused on better health through information and technology. His previous roles have included serving as Chief Medical Information Officer (CMIO), Advocate Aurora Health; CMIO, Cleveland Clinic Abu Dhabi (CCAD); Director of Global Programs and Healthcare Informatics, Partners Harvard Medical International’s (PHMI); and, Medical Director of Clinical Information Systems at Johns Hopkins Community Physicians.
Takashi Sugiyama Techlico Inc.
Established Techlico Inc. in April 2005. While developing various programs such as web systems, smartphone apps, social games, etc., a Rehamaru project started in 2017 triggered by the experience that friend's stroke.
Mizuho Nakanishi JETRO, Digital Trade and new Industry Department, New Industry Deveopment Division
Mizuho Nakanishi graduated from the Waseda University School of Political Science and Economics, Department of Economics. After acquiring her MA in Intercultural Management from the School for International Training in the United States, Mizuho Nakanishi worked on the establishment, screening, and approval of yen-dominated loans for Thailand at the Japan Bank for International Cooperation (JBIC) Head Office, and management of Japanese yen-dominated loan projects at the Japan International Cooperation Agency (JICA) Turkey Office. After serving at embassies and in the Japanese Ministry of Foreign Affairs, she joined the Japan External Trade Organization (JETRO). She gained experience in projects designed to support infrastructure export, start-ups, open innovations, etc. Since April 2019, she has been assigned to her current post. She provides support for hospitals, the export of medical equipment, and digital health promotion.
Tomoko Inoue CEO, Omron Ventures Co., Ltd.
Tomoko Inoue is a venture capitalist with rich experience in healthcare. Prior to joining OMRON Ventures, she was a founding member of a unique venture capital firm that focused on medical devices and invested in seed to early-stage startups primarily in Silicon Valley and Japan. She was born in the US, and grew up in the US, Germany and Japan. She loves to explore what she has not seen, and always seeks to go beyond the boundary. She has a PhD in Biomedical Science, an MBA from the Wharton School at the University of Pennsylvania, and is a Faculty Fellow of Stanford University’s Biodesign program.
Jeremy Rassen President & Chief Science Officer, Aetion
Jeremy A. Rassen, MS, ScD is co-founder, president, and chief science officer at Aetion, a health care technology company that delivers real-world evidence for life sciences companies, payers, and regulatory agencies. Prior to founding Aetion, Dr. Rassen was Assistant Professor of Medicine at Harvard Medical School, where he focused on methods to improve the quality and validity of real-world data studies. He also worked in Silicon Valley in a variety of tech companies. Dr. Rassen received his bachelor’s degree in Computer Science from Harvard College and his master’s and doctorate degrees in Epidemiology from the Harvard T.H. Chan School of Public Health.
Ken Iwasaki CEO, H2L, Inc.
Ken Iwasaki got his B.S. (Biochemistry) and M.S. (Computer Science) in 2008, 2010, respectively. His main research area is Human Computer Interaction. When he was a graduate student, he was selected as a creator of IPA:Exploratory IT Human Resources Project (The MITOH Program) and learned R&D and project management. After he graduated, he experienced business consulting at Accenture, and R&D management at RIKEN (Brain Science Institute). In 2012, he co-founded H2L, Inc. with Dr. Tamaki and Dr. Kamada. He takes advantage of his unique experience of both business and research to make research-stage technologies into products.
Shingo Tsuda Sponsor of TECH for LIFE, Co-founder and Technical Director, INDEE Japan
Co-founder and Technical Director, INDEE Japan
Cofounded INDEE Japan, an accelerator for innovation projects after R&D experience at IBM. Also cofounded ZENTECH DOJO Nihonbashi, a hands-on seed accelerator program mainly focusing on life sciences. Holds 18 patents in various fields. BE, Waseda Univ.
Yo Iwami President & CEO (M.D, Ph.D), MedPeer, Inc.
Dr. Iwami graduated from the Shinshu University School of Medicine and joined the Department of Cardiovascular Medicine at Tokyo Women's Medical University in 1999.
Yo established Medical Oblige Inc (now MedPeer,Inc.) in December 2004.
He launched MedPeer in August 2007.
MedPeer is a professional online social media for certified doctors to share insight of actual medical scene and now it holds more than 100,000 doctors (one of three doctors in Japan).
He continues to be active on the front lines of clinical site, still holding patient consultations once a week.
Michikazu Koshiba Head, Center on Global Health Architecture, General Manager, Social Impact Partnership Business Dept, Mitsubishi UFJ Research and Consulting Co., Ltd.
He started his career in International Development/Humanitarian Relief fields. Serving for disaster-affected community, the concept of sustainability/multi-stakeholder approach became the essential value for his career. Shaping his career as a consultant to dedicate his life to CSV(Creating Shared Values) business, especially on global health from the mid-2000s, he has worked with scores of corporations and startups, as well as with industry bodies, government, the media, NGOs, academia.
His favorite word of his role: “nexus between conventional politics and one of the future” Since 2016, he established a P3 forum “Access to Health” where the members are focusing on a contribution to global health including Infectious Diseases, Nutrition, NCDs, MCH and health service delivery to transform health system. Digital health is a key component. He plays a role as a facilitator/coordinator for multi-stakeholders in a global arena, working as the HEAD, Center on Global Health Architecture, MITSUBISHI UFJ Research and Consulting.
Tak Miyata General Partner, Scrum Ventures
Tak has invested in over 60 startups related to commerce, health care, SaaS, video, and IoT in the U.S. Tak has international experience in the IT industry both as an entrepreneur and as a senior executive.
Kazuo Tsubota, MD, PhD, MBA Professor & Department Chair, Keio University School of Medicine
Prof. Kazuo Tsubota is an internationally recognized dry eye specialist who has been working on the pathogenesis and treatment of dry eye for much of his career. His latest research activities spotlight myopia due to the myopia boom affecting Japan and East Asia. His research focuses on the hypothesis that violet light has a suppressive effect against the progression of myopia and blue light’s role in determining circadian rhythm, mood, and memory. More recently, Prof. Tsubota is interested in innovation and is director of the innovation program at Keio University which encourages researchers to start venture companies based on their scientific findings. To set an example he established his own company, Tsubota Laboratory, Inc. which focuses on the clinical application of violet light for the control of myopia as well as dry eye and presbyopia. In addition, Prof. Tsubota has published over 700 scientific peer-reviewed articles.
Rami Suzuki PhD Head, Medical Affairs Division, Janssen Pharmaceuticals K.K.
Rami Suzuki Ph.D. is Head of Medical Affairs at Janssen Pharmaceuticals K.K., the Janssen Pharmaceutical Companies of Johnson & Johnson. Today she serves Ministry of Education, Culture, Sports, Science and Technology as Life Science Committee member as well as AMED and JST as an advisor to several projects. She was a selection committee member of Medical Science and Medicinal Science for Japan Prize 2018. She obtained Ph.D. in Medicine at University College London with a scholarship from Ludwig Institute for Cancer Research. Her post doctorial research was on breast cancer at Imperial College, London. She also worked as a venture capitalist for life sciences in London before joining the pharmaceutical industry. Her lifetime missions are to cure cancer and to prevent dementia.
Tak Umezawa Japan Chairman, A.T. Kearney Chairman, CIC Japan
As Chairman of CIC Japan, Tak Umezawa is leading the effort to launch in 2020 CIC Tokyo, which will be the largest startup campus in the central Tokyo.
As Partner with A.T. Kearney, Umezawa has served leading corporations in Japan and the US for more than 20 years. Areas of his expertise include growth strategy, innovation and organization. He has served the firm as a Board Director, Japan MD, and the Global Leader of the Consumer Industries and Retail Practice.
Umezawa sits on government committees on Cool Japan, intellectual property, and inbound tourism. He is Adjunct Professor on leadership at Hitotsubashi ICS, Hitotsubashi University Business School.
Umezawa leads a multi-disciplinary, pro-bono team “NEXTOKYO.” The team has developed a future-city vision for Tokyo and works with property developers and municipalities on urban development projects in the city.
He has authored several books including “NEXTOKYO” (co-authored). He holds a bachelor of law from the University of Tokyo and an MBA from MIT Sloan School of Management.
Masao Okazaki Client Partner Country Lead, Pfizer Digital Japan, Pfizer Holdings G.K.
Joined in Pfizer-Taito in 1983 as MR. Assigned as an initial member to establish a new medical device division of Pfizer in Japan. In 1992, he took the role of IT Manager of Pfizer Hospital Products Group. In 1996, he held a role of Senior IT Manager of Pfizer's Pharmaceutical division and supported its Sales and Marketing businesses and processes including SFA, SFE, CRM, eMarketing, Mobile etc. Senior Director, Business Technology in 1999 in Japan and New York HQ after 2002. Pfizer Digital Japan Lead since 2019.
Tomoyoshi Sato Representative Director CEO&CTO, AXION RESEARCH INC.
In Mar., 2000 I started IPFlex Inc. that provides dynamically recofigurable processors based on parallel data processing with cycle base data path changes, targeting moving picture processing for digital TV or smart phone application. In Oct., 2009 I started Atonarp Inc. that provides very companct Mass Spectrometer to be used for breath monitoring or environment air analysis, and Optical Spectrometer targetting the nonivasive quantitative measurement of blood inspection like blood glucose or HbA1c. We have Replica Generator to enable the data creation, very close to the measured data with keeping closely the correlation, the covariance and the probability density of those data. By the hybrid type engine of knowledge base engine and deep learning engine, we established AXiON Research Inc. in Dec., 2016 for inference of the individual health position and the future disease risk. We continue those challenge for the next future society happiness and people's big smiles there.
Shigeo Kohigashi CEO, Enishia,Inc.
After graduating from the Faculty of Economics at Osaka University in 1999, he worked for financial institutions, foreign accounting consulting companies and local governments. Experienced in large-scale group management management infrastructure development projects. Knowledge of project management from start-up to stable operation.
Acquired Kyoto University MBA (Service Value Creation Program) in 2017. Participated in the “Kyoto University Design School” that nurtures social system and architecture design personnel while in graduate school, the “EDGE Program” that nurtures global entrepreneurs, and “HiDEP” that nurtures medical healthcare innovation entrepreneurs.
Yutaka Shimokawa CEO, KINS
The former chairman of Iaso Kai Association of Medical Corporations, He worked at the clinic 6year and he also followed as Chairman 3years.
He provided medical treatment aggressively while focusing on management. Especially he approached the definitive care treatment on the bacteria flora for more than 2,500 chronic disease patients or designated intractable disease patients.
During his treatment, he found the lifestyle of the patients were “widely different from the proper daily life which need to live” during medical treatment, such as, bread with gluten, toothpaste with surfactant, processed food with lots of preservatives, and sweets with lots of sugar etc...
These series were creating chronic inflammation all over their body caused disturbing the balance of the symbiotic bacteria. He wanted to share this fact to more people for regaining proper daily life of the patients, and then he has founded KINS.
Adebayo Alonge CoFounder/CEO, RxAll Inc.
Market development professional with 10+ years experience developing 100M+ new business in Africa for BCG, BASF, Roche and Sanofi. Pharmacist with business & policy degrees from Yale and Harvard (in-view).
Tamaryn Hankinson Co-founder and Managing Director, The Clinician
Mrs. Tamaryn Hankinson graduated from Otago University in New Zealand with a 1st class honours degree in Neuroscience in 1998. Tamaryn worked in the pharmaceutical industry in Australia and the UK before moving into business intelligence in the healthcare sector in 2003 where she worked in senior executive positions for more than a decade across Europe and the US. In 2015 Dr. Ron Tenenbaum (a spinal surgeon with strong technological background) and Tamaryn formed the health software company The Clinician developing software solutions to support the global shift to value based care models. After launching their outcome and cost measurement platform ZEDOC in Singapore where they are now implementing naitonally, The Clinician also has significant traction in Israel and Australia, winning a national tender with the Australian Digital Health Agency to evaluate for national scalibility.